NCT05754593View on ClinicalTrials.gov

Study of Ovarian Reserve Concerning Patients With Multiple Sclerosis (MS), Compared to a Control Group

NARecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

December 4, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Multiple Sclerosis
Interventions
BIOLOGICAL

Anti-Mullerian hormone (AMH) level

Measure of Anti-Mullerian hormone (AMH) level by blood sample

OTHER

Antral follicle count (AFC)

Measure of Antral follicle count (AFC) by ultrasound imaging

OTHER

Clinical assessment

MS history and MS treatments and Expanded Disability Status Scale (EDSS) score will be recorded

Trial Locations (1)

Unknown

RECRUITING

CHU de Bordeaux - service de neurologie, Bordeaux

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER